Merck's Chief Executive Richard Clark said the drug maker was open to buying a big rival, signaling a shift for a company that long maintained its research prowess was enough to keep it growing.
In a conference call with analysts after reporting better-than-expected earnings, Mr. Clark said Merck would look "across the whole spectrum" of deals, including a major takeover. "I don't think in today's world any CEO can categorically rule out any type of transaction," he said.
No comments:
Post a Comment